Antiplatelet therapy and the anaesthetist | ||||
| The Egyptian Journal of Cardiothoracic Anesthesia | ||||
| Volume 13, Issue 1, January 2019 PDF (1.19 MB) | ||||
| DOI: 10.4103/ejca.ejca_18_18 | ||||
 View on SCiNiTO | ||||
| Author | ||||
| Dina H. Elbarbary | ||||
| Abstract | ||||
| Increasing numbers of patients internationally are taking dual antiplatelet therapy (DAPT). Both continuing and stopping this treatment may be risky for the patient. It is vital to consider the competing thrombotic and bleeding risks in the perioperative period. It is incumbent upon anaesthetists to maintain their knowledge base in this rapidly developing area. This article provides information to support practice as. | ||||
| Keywords | ||||
| antiplatelet agents; Bleeding; Thrombosis | ||||
|
Statistics Article View: 36 PDF Download: 30 |
||||
